A
ACADIA Pharmaceuticals Inc.
ACAD · NASDAQ · Healthcare · 4.8B
Price · close
$29.50
+1.58% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
12.8×
Price / net assetsP/B
4.1×
Enterprise value / EBITDAEV/EBITDA
32.3×
Free cash flow yieldFCF yield
2.1%
Return on equityROE
31.9%
Operating margin
9.8%
Net debt / EBITDAbalance-sheet strength
-0.8×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.